- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1417
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1,417 companies
Eli Lilly
Market Cap: US$677.9b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$747.01
7D
0.1%
1Y
-7.0%
Johnson & Johnson
Market Cap: US$366.9b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$153.66
7D
3.5%
1Y
1.6%
AbbVie
Market Cap: US$328.0b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$184.85
7D
-1.7%
1Y
13.5%
Novo Nordisk
Market Cap: DKK 2.0t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 456.15
7D
4.0%
1Y
-50.8%
Roche Holding
Market Cap: CHF 211.2b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 263.40
7D
1.7%
1Y
12.4%
Novartis
Market Cap: CHF 182.8b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 93.29
7D
3.5%
1Y
-0.6%
AstraZeneca
Market Cap: UK£161.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£104.18
7D
2.3%
1Y
-15.7%
Merck
Market Cap: US$193.9b
Operates as a healthcare company worldwide.
MRK
US$77.97
7D
1.7%
1Y
-40.4%
Thermo Fisher Scientific
Market Cap: US$156.3b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
US$413.75
7D
-3.5%
1Y
-29.9%
Amgen
Market Cap: US$148.3b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$275.01
7D
1.7%
1Y
-12.7%
Danaher
Market Cap: US$140.6b
Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
DHR
US$197.77
7D
0.6%
1Y
-25.8%
Gilead Sciences
Market Cap: US$132.1b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$109.11
7D
7.6%
1Y
62.1%
Pfizer
Market Cap: US$130.8b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$23.52
7D
2.8%
1Y
-17.6%
Sanofi
Market Cap: €113.9b
A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
SAN
€93.52
7D
4.2%
1Y
3.9%
Vertex Pharmaceuticals
Market Cap: US$113.2b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$447.18
7D
3.5%
1Y
1.2%
Bristol-Myers Squibb
Market Cap: US$96.1b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$47.87
7D
2.7%
1Y
13.2%
Chugai Pharmaceutical
Market Cap: JP¥12.5t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,393.00
7D
-1.4%
1Y
52.6%
GSK
Market Cap: UK£57.5b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£14.16
7D
4.2%
1Y
-19.4%
CSL
Market Cap: AU$118.2b
Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$245.21
7D
2.3%
1Y
-11.8%
Zoetis
Market Cap: US$73.0b
Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.
ZTS
US$163.65
7D
2.0%
1Y
-5.3%
Regeneron Pharmaceuticals
Market Cap: US$63.0b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
REGN
US$614.79
7D
7.1%
1Y
-38.1%
Merck KGaA
Market Cap: €51.0b
Operates as a science and technology company in Germany.
MRK
€117.20
7D
-7.2%
1Y
-29.3%
Samsung BiologicsLtd
Market Cap: ₩73.1t
Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,100,000.00
7D
9.5%
1Y
41.6%
Haleon
Market Cap: UK£36.8b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£4.09
7D
3.3%
1Y
23.4%
Sun Pharmaceutical Industries
Market Cap: ₹4.1t
A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally.
SUNPHARMA
₹1,731.80
7D
1.4%
1Y
12.5%
Daiichi Sankyo Company
Market Cap: JP¥6.9t
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
4568
JP¥3,721.00
7D
9.8%
1Y
-31.4%
Takeda Pharmaceutical
Market Cap: JP¥6.4t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥4,134.00
7D
1.3%
1Y
0.8%
Alnylam Pharmaceuticals
Market Cap: US$38.1b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$291.68
7D
9.3%
1Y
94.9%
argenx
Market Cap: €31.4b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€513.60
7D
5.1%
1Y
55.7%
UCB
Market Cap: €30.6b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€161.10
7D
2.8%
1Y
25.5%
Agilent Technologies
Market Cap: US$32.3b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
A
US$113.48
7D
-1.7%
1Y
-26.2%
Galderma Group
Market Cap: CHF 24.3b
Operates as a dermatology company worldwide.
GALD
CHF 102.20
7D
4.3%
1Y
36.9%
Bayer
Market Cap: €23.0b
Operates as a life science company worldwide.
BAYN
€23.43
7D
-5.3%
1Y
-17.3%
BeiGene
Market Cap: US$25.2b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$236.86
7D
5.4%
1Y
41.5%
WuXi AppTec
Market Cap: CN¥178.5b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥62.05
7D
1.7%
1Y
40.6%
Otsuka Holdings
Market Cap: JP¥3.5t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥6,622.00
7D
-0.9%
1Y
4.3%